Wound Care (Pharmacies) - Malaysia

  • Malaysia
  • Revenue in the Wound Care market is projected to reach US$6.92m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2028) of 0.93%, resulting in a market volume of US$7.18m by 2028.
  • In global comparison, most revenue will be generated in the United States (US$1,042.00m in 2024).
  • In relation to total population figures, per person revenues of US$0.20 are generated in 2024.

Key regions: South Korea, United States, Canada, United Kingdom, Australia

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Wound Care (Pharmacies) market in Malaysia has been experiencing steady growth in recent years.

Customer preferences:
Customers in Malaysia have shown a growing preference for wound care products available in pharmacies. This can be attributed to several factors. Firstly, pharmacies offer convenience and accessibility to customers, as they are often located in easily accessible areas such as shopping malls and residential neighborhoods. Additionally, pharmacies provide a wide range of wound care products, allowing customers to choose from different brands and types of products based on their specific needs.

Trends in the market:
One major trend in the Wound Care (Pharmacies) market in Malaysia is the increasing demand for advanced wound care products. As customers become more aware of the benefits of advanced wound care products, they are willing to invest in higher quality products that promote faster healing and reduce the risk of infection. This trend is driven by factors such as an aging population, an increase in chronic diseases, and a growing emphasis on healthcare and wellness. Another trend in the market is the rising popularity of natural and organic wound care products. Customers in Malaysia are becoming more conscious of the ingredients used in the products they use on their wounds, and are seeking out products that are made from natural or organic materials. This trend is in line with the global shift towards natural and organic products in various industries, including healthcare.

Local special circumstances:
One unique aspect of the Wound Care (Pharmacies) market in Malaysia is the influence of traditional medicine. Traditional medicine, including herbal remedies and traditional healing practices, has a long history in Malaysia and continues to be widely practiced. This has led to a demand for wound care products that incorporate traditional ingredients and methods. Pharmacies in Malaysia often stock a range of traditional wound care products alongside modern products, catering to customers who prefer traditional remedies.

Underlying macroeconomic factors:
The growth of the Wound Care (Pharmacies) market in Malaysia can be attributed to several underlying macroeconomic factors. Firstly, Malaysia has experienced sustained economic growth in recent years, leading to an increase in disposable income and a higher standard of living. This has allowed customers to allocate more of their budget towards healthcare and wellness products, including wound care products. Additionally, the healthcare sector in Malaysia has been expanding, with increased investment in healthcare infrastructure and services. This has led to improved access to healthcare facilities and a greater emphasis on preventive care, including wound care. The government has also implemented initiatives to promote healthcare and wellness, further driving the demand for wound care products. In conclusion, the Wound Care (Pharmacies) market in Malaysia is developing due to customer preferences for convenient access to a wide range of products, as well as the increasing demand for advanced and natural wound care products. The influence of traditional medicine and the underlying macroeconomic factors of sustained economic growth and investment in healthcare also contribute to the market's growth.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)